Big setback for Medanta Hospital, pharmacy licence suspended after death of boy
The action against Medanta Hospital came nearly a month after the medical board submitted its report on March 5, and almost a week after the father of Saurya Pratap stated at a press conference that he accepted the reimbursement of his son’s treatment cost from Medanta Hospital, with a promise that he would not pursue legal case against the hospital.
)
02:39 PM IST
The licence of Medanta Hospital’s internal pharmacy has been suspended for 7 days, following a notice issued by the Health department, said a Zee Business report today. The Gurugram hospital was found to have allegedly violated the norms when the complaint by Gopendra Pratap, the father of seven-year-old boy Saurya Pratap who died last year from a dengue infection, was being probed.
The action against Medanta Hospital came nearly a month after the medical board submitted its report on March 5, and almost a week after the father of Saurya Pratap stated at a press conference that he accepted the reimbursement of his son’s treatment cost from Medanta Hospital, with a promise that he would not pursue legal case against the hospital.
The boy's father had alleged that the hospital had made an inflated bill of Rs 15.88 lakh, compelling him to file a case against the hospital. The boy was admitted to the hospital on October 30, 2017, suffering from severe dengue with multi-organ dysfunction syndrome.
Saurya Pratap was later shifted to Ram Manohar Lohia Hospital in Delhi on November 20, as there was no improvement in his condition. He died on November 22 at the RML.
Watch this Zee Business video
The boy's father Gopendra, an LIC agent from Rajasthan’s Dhaulpur district, had to mortgage his house to pay the treatment cost.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
)
)
)
)
)
)
)
)
)
Global Health Q1 Results: Company reports Rs 102 crore profit
EXCLUSIVE: Medanta growing 20 per cent every year from 2020 to 2022, and will continue to grow, says Global Health CEO Pankaj Sahani
Shares of Medanta operator Global Health close 24% higher on debut trade: Experts recommend if investors should buy, sell or hold 
Medanta brand-owner Global Health files IPO papers with Sebi
Top Gurugram hospitals flouting rules, inspection reveals
